Center offers new cutting edge technology to correct sleep apnea while providing facial cosmetic benefits for obstructive sleep apnea sufferers. New technology addresses root cause of sleep apnea by non-surgically remodeling the upper airway.
Sugar Land, TX (PRWEB) January 17, 2013
Dr. Samuel E. Cress, D.D.S., Director of Sugar Land’s The Center for Craniofacial & Dental Sleep Medicine, offers new DNA therapy to aid patients suffering from Obstructive Sleep Apnea. Obstructive Sleep Apnea (OSA).
OSA is present in approximately one in every 15 Americans. More astonishing, over five percent of all Americans have undiagnosed cases of sleep apnea and are living with a very treatable disease. CPAPs are typical OSA treatment options and used to alleviate the symptoms of OSA, while the DNA appliance addresses the root cause by non-surgically remodeling the upper airway.
The DNA, short for “Daytime Nighttime Appliance”, system is unique because it was not only developed to correct sleep apnea symptoms, it also straightens teeth and improves the upper airway. By improving the upper airway through an increase in facial volume, a cosmetic benefit of facial feature balancing occurs.
The patented DNA system uses DNA wire TM and patented 3D axial springs TM to store kinetic energy, which is then released at night during the growth hormone circadian rhythm. This stored-energy is necessary to initiate cellular growth in the mid-face and mandible. It increases upper mid-facial volume for better airway exchange and helps establish a more ideal occlusion, at the same time leading to a noninvasive facial cosmetic correction. Results have been present in as little as 90 days.
“I personally have been using the DNA sleep apnea appliance in my practice for more than 3 years and have over 150 of these in place. The astonishing results have not only improved the patient’s airways and straightened their teeth, but have also improved their facial features,” Dr. Cress reported. “We are seeing broader smiles, fuller lips, better and straighter noses--leading to happier, healthier patients.”
Dr. Cress studied the DNA system under the guidance of Dr. Dave Singh, D.D.Sc., Ph.D., B.D.S., the sole inventor of the DNA. To learn more about Dr. Cress and the DNA system, visit http://www.cfdsm.com /OSA. Dr. Cress will be lecturing in Salt Lake City in Utah, January 24th through 26th.
About Dr. Samuel E. Cress, D.D.S.
Director of the Center for Craniofacial & Dental Sleep Medicine, located in Sugar Land, Texas, Dr. Cress completed his Doctorate of Dental Surgery at the University of Texas Health Science Center, San Antonio and his residency in Dental Sleep Medicine at Tufts University School of Dental Medicine in Boston, Mass.
Dr. Cress’s practice includes general cosmetic dentistry and dental sleep medicine, treating patients in the Houston area for nearly 20 years. A nationally-recognized industry leader and instructor in Sleep Medicine Appliance Therapies, Dr. Cress is a distinguished clinical instructor in the prestigious Dr. Dick Barnes Group in conjunction with Arrowhead Dental Lab.
Dr. Cress is a member of the American Academy of Dental Sleep Medicine, American Academy of Craniofacial Pain, American and Texas Dental Associations, the Academy of General Dentistry and the Greater Houston Dental Society. Dr. Cress and his wife, Kimberly Cress, M.D., share their life with their son Carter.
The Center for Craniofacial Dental Sleep Medicine
The Center for Craniofacial Dental Sleep Medicine, located in Sugar Land, Texas, helps patients overcome issues with obstructive sleep apnea, snoring and malocclusions. Using industry best-practices and leading the adoption of new technologies, the Center for Craniofacial Dental Sleep Medicine places patient care and quality of life above all else. For more information on The Center for Craniofacial and Dental Sleep Medicine visit http://www.cfdsm.com.
Virginia Stovall (media)
Dr. Samuel E. Cress D.D.S.
The Center for Craniofacial and Dental Sleep Medicine
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/1/prweb10323693.htm